Clinical Trial Update: Overcoming High On-Treatment Platelet Reactivity (HPR) During Prasugrel Therapy With Ticagrelor [Phase 4]

View source ↗

Summary

Phase 4 clinical trial exploring whether ticagrelor can overcome high on-treatment platelet reactivity in patients receiving prasugrel for coronary artery disea…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease

Drugs mentioned

• Prasugrel (Effient) (prasugrel)
• ticagrelor (Brilinta) (ticagrelor)

Snippet

Sponsor: LifeBridge Health | Conditions: Coronary Artery Disease | Phase 4 | Status: UNKNOWN